<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34452307</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>23</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Serological Evidence of Widespread Zika Transmission across the Philippines.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1441</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v13081441</ELocationID><Abstract><AbstractText>Zika virus (ZIKV) exposure across flavivirus-endemic countries, including the Philippines, remains largely unknown despite sporadic case reporting and environmental suitability for transmission. Using laboratory surveillance data from 2016, 997 serum samples were randomly selected from suspected dengue (DENV) case reports across the Philippines and assayed for serological markers of short-term (IgM) and long-term (IgG) ZIKV exposure. Using mixture models, we re-evaluated ZIKV IgM/G seroprevalence thresholds and used catalytic models to quantify the force of infection (attack rate, AR) from age-accumulated ZIKV exposure. While we observed extensive ZIKV/DENV IgG cross-reactivity, not all individuals with active DENV presented with elevated ZIKV IgG, and a proportion of dengue-negative cases (DENV IgG-) were ZIKV IgG-positive (14.3%, 9/63). We identified evidence of long-term, yet not short-term, ZIKV exposure across Philippine regions (ZIKV IgG+: 31.5%, 314/997) which was geographically uncorrelated with DENV exposure. In contrast to the DENV AR (12.7% (95%CI: 9.1-17.4%)), the ZIKV AR was lower (5.7% (95%CI: 3-11%)) across the country. Our results provide evidence of widespread ZIKV exposure across the Philippines and suggest the need for studies to identify ZIKV infection risk factors over time to better prepare for potential future outbreaks.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Biggs</LastName><ForeName>Joseph R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0001-7273-874X</Identifier><AffiliationInfo><Affiliation>Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sy</LastName><ForeName>Ava Kristy</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Virology, Research Institute for Tropical Medicine, Manila 1781, Philippines.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dengue Study Group, Research Institute for Tropical Medicine, Manila 1781, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brady</LastName><ForeName>Oliver J</ForeName><Initials>OJ</Initials><Identifier Source="ORCID">0000-0002-3235-2129</Identifier><AffiliationInfo><Affiliation>Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kucharski</LastName><ForeName>Adam J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Funk</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tu</LastName><ForeName>Yun-Hung</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Molecular Parasitology and Tropical Diseases, Graduate Institute of Medical Sciences, Taipei Medical University, Taipei 11031, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes</LastName><ForeName>Mary Anne Joy</ForeName><Initials>MAJ</Initials><AffiliationInfo><Affiliation>Department of Virology, Research Institute for Tropical Medicine, Manila 1781, Philippines.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dengue Study Group, Research Institute for Tropical Medicine, Manila 1781, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinones</LastName><ForeName>Mary Ann</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Virology, Research Institute for Tropical Medicine, Manila 1781, Philippines.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dengue Study Group, Research Institute for Tropical Medicine, Manila 1781, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones-Warner</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashall</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avelino</LastName><ForeName>Ferchito L</ForeName><Initials>FL</Initials><AffiliationInfo><Affiliation>Department of Health, Philippine Epidemiology Bureau, Manila 1003, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sucaldito</LastName><ForeName>Nemia L</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>Department of Health, Philippine Epidemiology Bureau, Manila 1003, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tandoc</LastName><ForeName>Amado O</ForeName><Initials>AO</Initials><Identifier Source="ORCID">0000-0002-2186-4989</Identifier><AffiliationInfo><Affiliation>Department of Virology, Research Institute for Tropical Medicine, Manila 1781, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cutiongco-de la Paz</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Human Genetics, University of the Philippines, Manila 1000, Philippines.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Philippine Genome Centre, University of the Philippines, Manila 1101, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capeding</LastName><ForeName>Maria Rosario Z</ForeName><Initials>MRZ</Initials><AffiliationInfo><Affiliation>Dengue Study Group, Research Institute for Tropical Medicine, Manila 1781, Philippines.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Human Genetics, University of the Philippines, Manila 1000, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Padilla</LastName><ForeName>Carmencita D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Institute of Human Genetics, University of the Philippines, Manila 1000, Philippines.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Philippine Genome Centre, University of the Philippines, Manila 1101, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hibberd</LastName><ForeName>Martin L</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0001-8587-1849</Identifier><AffiliationInfo><Affiliation>Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Human Genetics, University of the Philippines, Manila 1000, Philippines.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Philippine Genome Centre, University of the Philippines, Manila 1101, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hafalla</LastName><ForeName>Julius Clemence R</ForeName><Initials>JCR</Initials><AffiliationInfo><Affiliation>Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>206250/Z/17/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/V031112/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>206471/Z/17/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007075">Immunoglobulin M</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007075" MajorTopicYN="N">Immunoglobulin M</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010679" MajorTopicYN="N" Type="Geographic">Philippines</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071244" MajorTopicYN="N">Zika Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071243" MajorTopicYN="N">Zika Virus Infection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Philippines</Keyword><Keyword MajorTopicYN="N">Zika</Keyword><Keyword MajorTopicYN="N">dengue</Keyword><Keyword MajorTopicYN="N">diagnostics</Keyword><Keyword MajorTopicYN="N">force of infection</Keyword><Keyword MajorTopicYN="N">serology</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>28</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34452307</ArticleId><ArticleId IdType="pmc">PMC8402696</ArticleId><ArticleId IdType="doi">10.3390/v13081441</ArticleId><ArticleId IdType="pii">v13081441</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization  Zika Epidemiological Update Report.  [(accessed on 14 July 2021)]; Available online:  https://www.who.int/emergencies/diseases/zika/zika-epidemiology-update-july-2019.pdf.</Citation></Reference><Reference><Citation>Lowe R., Barcellos C., Brasil P., Cruz O.G., Hon&#xf3;rio N.A., Kuper H., Carvalho M.S. The Zika Virus Epidemic in Brazil: From Discovery to Future Implications. Int. J. Environ. Res. Public Health. 2018;15:96. doi: 10.3390/ijerph15010096.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph15010096</ArticleId><ArticleId IdType="pmc">PMC5800195</ArticleId><ArticleId IdType="pubmed">29315224</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao-Lormeau V.-M., Blake A., Mons S., Last&#xe8;re S., Roche C., Vanhomwegen J., Dub T., Baudouin L., Teissier A., Larre P., et al. Guillain-Barr&#xe9; Syndrome outbreak associated with Zika virus infection in French Polynesia: A case-control study. Lancet. 2016;387:1531&#x2013;1539. doi: 10.1016/S0140-6736(16)00562-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)00562-6</ArticleId><ArticleId IdType="pmc">PMC5444521</ArticleId><ArticleId IdType="pubmed">26948433</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady O.J., Osgood-Zimmerman A., Kassebaum N.J., Ray S.E., de Ara&#xfa;jo V.E.M., Da N&#xf3;brega A.A., Frutuoso L.C.V., Lecca R.C.R., Stevens A., Zoca de Oliveira B., et al. The association between Zika virus infection and microcephaly in Brazil 2015-2017: An observational analysis of over 4 million births. PLoS Med. 2019;16:e1002755. doi: 10.1371/journal.pmed.1002755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002755</ArticleId><ArticleId IdType="pmc">PMC6400331</ArticleId><ArticleId IdType="pubmed">30835728</ArticleId></ArticleIdList></Reference><Reference><Citation>Lessler J., Chaisson L.H., Kucirka L.M., Bi Q., Grantz K., Salje H., Carcelen A.C., Ott C.T., Sheffield J.S., Ferguson N.M., et al. Assessing the global threat from Zika virus. Science. 2016;353:aaf8160. doi: 10.1126/science.aaf8160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf8160</ArticleId><ArticleId IdType="pmc">PMC5467639</ArticleId><ArticleId IdType="pubmed">27417495</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruchusatsawat K., Wongjaroen P., Posanacharoen A., Rodriguez-Barraquer I., Sangkitporn S., Cummings D.A.T., Salje H. Long-term circulation of Zika virus in Thailand: An observational study. Lancet Infect. Dis. 2019;19:439&#x2013;446. doi: 10.1016/S1473-3099(18)30718-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(18)30718-7</ArticleId><ArticleId IdType="pmc">PMC6511259</ArticleId><ArticleId IdType="pubmed">30826189</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Barraquer I., Costa F., Nascimento E.J.M., Nery N., Castanha P.M.S., Sacramento G.A., Cruz J., Carvalho M., De Olivera D., Hagan J.E., et al. Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region. Science. 2019;363:607&#x2013;610. doi: 10.1126/science.aav6618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav6618</ArticleId><ArticleId IdType="pmc">PMC8221194</ArticleId><ArticleId IdType="pubmed">30733412</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng D.H.L., Ho H.J., Chow A., Wong J., Kyaw W.M., Tan A., Chia P.Y., Choy C.Y., Tan G., Yeo T.W., et al. Correlation of clinical illness with viremia in Zika virus disease during an outbreak in Singapore. BMC Infect. Dis. 2018;18:1&#x2013;7. doi: 10.1186/s12879-018-3211-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-018-3211-9</ArticleId><ArticleId IdType="pmc">PMC6030762</ArticleId><ArticleId IdType="pubmed">29973158</ArticleId></ArticleIdList></Reference><Reference><Citation>Okafor I.I. Zika Virus: The Emerging Global Health Challenge. Divers. Equal. Health Care. 2016;13 doi: 10.21767/2049-5471.100083.</Citation><ArticleIdList><ArticleId IdType="doi">10.21767/2049-5471.100083</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone M., Bakkour S., Lanteri M.C., Brambilla D., Simmons G., Bruhn R., Kaidarova Z., Lee T.H., Orlando Alsina J., Williamson P.C., et al. Zika virus RNA and IgM persistence in blood compartments and body fluids: A prospective observational study. Lancet Infect. Dis. 2020;20:1446&#x2013;1456. doi: 10.1016/S1473-3099(19)30708-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(19)30708-X</ArticleId><ArticleId IdType="pubmed">32673593</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasquier C., Joguet G., Mengelle C., Chapuy-Regaud S., Pavili L., Prisant N., Izopet J., Bujan L., Mansuy J.M. Kinetics of anti-ZIKV antibodies after Zika infection using two commercial enzyme-linked immunoassays. Diagn. Microbiol. Infect. Dis. 2018;90:26&#x2013;30. doi: 10.1016/j.diagmicrobio.2017.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2017.09.001</ArticleId><ArticleId IdType="pubmed">29107414</ArticleId></ArticleIdList></Reference><Reference><Citation>St John A.L., Rathore A.P.S. Adaptive immune responses to primary and secondary dengue virus infections. Nat. Rev. Immunol. 2019;19:218&#x2013;230. doi: 10.1038/s41577-019-0123-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-019-0123-x</ArticleId><ArticleId IdType="pubmed">30679808</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead S.B. Dengue Antibody-Dependent Enhancement: Knowns and Unknowns. Microbiol. Spectr. 2014;2 doi: 10.1128/microbiolspec.AID-0022-2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/microbiolspec.AID-0022-2014</ArticleId><ArticleId IdType="pubmed">26104444</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-Acebes M.A., Saiz J.-C., Jim&#xe9;nez de Oya N. Antibody-Dependent Enhancement and Zika: Real Threat or Phantom Menace? Front. Cell. Infect. Microbiol. 2018;8:44. doi: 10.3389/fcimb.2018.00044.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2018.00044</ArticleId><ArticleId IdType="pmc">PMC5818409</ArticleId><ArticleId IdType="pubmed">29497604</ArticleId></ArticleIdList></Reference><Reference><Citation>Culshaw A., Mongkolsapaya J., Screaton G.R. The immunopathology of dengue and Zika virus infections. Curr. Opin. Immunol. 2017;48:1&#x2013;6. doi: 10.1016/j.coi.2017.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2017.07.001</ArticleId><ArticleId IdType="pubmed">28738211</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzelnick L.C., Narvaez C., Arguello S., Lopez Mercado B., Collado D., Ampie O., Elizondo D., Miranda T., Bustos Carillo F., Mercado J.C., et al. Zika virus infection enhances future risk of severe dengue disease. Science. 2020;369:1123&#x2013;1128. doi: 10.1126/science.abb6143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb6143</ArticleId><ArticleId IdType="pmc">PMC8274975</ArticleId><ArticleId IdType="pubmed">32855339</ArticleId></ArticleIdList></Reference><Reference><Citation>George J., Valiant W.G., Mattapallil M.J., Walker M., Huang Y.-J.S., Vanlandingham D.L., Misamore J., Greenhouse J., Weiss D.E., Verthelyi D., et al. Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques. Sci. Rep. 2017;7:1&#x2013;10. doi: 10.1038/s41598-017-10901-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-10901-1</ArticleId><ArticleId IdType="pmc">PMC5585353</ArticleId><ArticleId IdType="pubmed">28874759</ArticleId></ArticleIdList></Reference><Reference><Citation>Ari&#xeb;n K.K., Michiels J., Foqu&#xe9; N., Heyndrickx L., Van Esbroeck M. Can Zika virus antibodies cross-protect against dengue virus? Lancet Glob. Health. 2018;6:e494. doi: 10.1016/S2214-109X(18)30122-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(18)30122-0</ArticleId><ArticleId IdType="pubmed">29653619</ArticleId></ArticleIdList></Reference><Reference><Citation>Valiant W.G., Huang Y.-J.S., Vanlandingham D.L., Higgs S., Lewis M.G., Mattapallil J.J. Zika convalescent macaques display delayed induction of anamnestic cross-neutralizing antibody responses after dengue infection. Emerg. Microbes Infect. 2018;7:130. doi: 10.1038/s41426-018-0132-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41426-018-0132-z</ArticleId><ArticleId IdType="pmc">PMC6045599</ArticleId><ArticleId IdType="pubmed">30006514</ArticleId></ArticleIdList></Reference><Reference><Citation>Elisa N.S. Zika Virus Infections EUROIMMUN Test Systems for the Diagnosis of Zika Virus Infections.  [(accessed on 14 July 2021)]; Available online:  https//:www.euroimmun.com/documents/Indications/Infections/Zika-virus/HI_2668_I_UK_B.pdf.</Citation></Reference><Reference><Citation>Huzly D., Hanselmann I., Schmidt-Chanasit J., Panning M. High specificity of a novel Zika virus ELISA in European patients after exposure to different flaviviruses. Eurosurveillance. 2016:21. doi: 10.2807/1560-7917.ES.2016.21.16.30203.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2016.21.16.30203</ArticleId><ArticleId IdType="pubmed">27126052</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinhagen K., Probst C., Radzimski C., Schmidt-Chanasit J., Emmerich P., Van Esbroeck M., Schinkel J., Grobusch M.P., Goorhuis A., Warnecke J.M., et al. Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: A multicohort study of assay performance, 2015 to 2016. Eurosurveillance. 2016;21:30426. doi: 10.2807/1560-7917.ES.2016.21.50.30426.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2016.21.50.30426</ArticleId><ArticleId IdType="pmc">PMC5291135</ArticleId><ArticleId IdType="pubmed">28006649</ArticleId></ArticleIdList></Reference><Reference><Citation>Medialdea-Carrera R., Levy F., Castanha P., de Sequeira P.C., Brasil P., Lewis-Ximenez L.L., Turtle L., Solomon T., Bispo de Filippis A.M., Brown D.W., et al. A systematic evaluation of IgM and IgG antibody assay accuracy in diagnosing acute Zika Virus infection in Brazil; lessons relevant to emerging infections. bioRxiv. 2020 doi: 10.1101/2020.11.25.399386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.25.399386</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuti M., Tauro L.B., Moreira P.S.S., Campos G.S., Paploski I.A.D., Weaver S.C., Reis M.G., Kitron U., Ribeiro G.S. Diagnostic performance of commercial IgM and IgG enzyme-linked immunoassays (ELISAs) for diagnosis of Zika virus infection. Virol. J. 2018;15:108. doi: 10.1186/s12985-018-1015-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-018-1015-6</ArticleId><ArticleId IdType="pmc">PMC6045861</ArticleId><ArticleId IdType="pubmed">30005683</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales I., Rosenberger K.D., Magalhaes T., Morais C.N.L., Braga C., Marques E.T.A., Calvet G.A., Damasceno L., Brasil P., Bispo de Filippis A.M., et al. Diagnostic performance of anti-Zika virus IgM, IgAM and IgG ELISAs during co-circulation of Zika, dengue, and chikungunya viruses in Brazil and Venezuela. PLoS Negl. Trop. Dis. 2021;15:e0009336. doi: 10.1371/journal.pntd.0009336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0009336</ArticleId><ArticleId IdType="pmc">PMC8084345</ArticleId><ArticleId IdType="pubmed">33872309</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao T., Wang X., Donolato M., Harris E., Cruz M.M., Balmaseda A., Wang R.Y.L. Evaluation of ViroTrack Sero Zika IgG/IgM, a New Rapid and Quantitative Zika Serological Diagnostic Assay. Diagnostics. 2020;10:372. doi: 10.3390/diagnostics10060372.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics10060372</ArticleId><ArticleId IdType="pmc">PMC7345115</ArticleId><ArticleId IdType="pubmed">32512812</ArticleId></ArticleIdList></Reference><Reference><Citation>Buerano C.C., Pangilinan L.A.S., Dimamay M.T.A., Mapua C.A., Dimamay M.P.S., Matias R.R., Natividad F.F., Daroy M.L.G., Hasebe F., Morita K., et al. Zika virus infection, philippines, 2012. Emerg. Infect. Dis. 2020;26:2300&#x2013;2301. doi: 10.3201/eid2609.190896.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2609.190896</ArticleId><ArticleId IdType="pmc">PMC7454108</ArticleId><ArticleId IdType="pubmed">32818418</ArticleId></ArticleIdList></Reference><Reference><Citation>Alera M.T., Hermann L., Tac-An I.A., Klungthong C., Rutvisuttinunt W., Manasatienkij W., Villa D., Thaisomboonsuk B., Velasco J.M., Chinnawirotpisan P., et al. Zika virus infection, philippines, 2012. Emerg. Infect. Dis. 2015;21:722&#x2013;724. doi: 10.3201/eid2104.141707.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2104.141707</ArticleId><ArticleId IdType="pmc">PMC4378478</ArticleId><ArticleId IdType="pubmed">25811410</ArticleId></ArticleIdList></Reference><Reference><Citation>Lonogan K., de Guzman A., Delos Reyes V.C., Sucaldito M.N., Avelino F. The enhanced Zika surveillance in the Philippines, November 14, 2016&#x2013;February 28, 2017. Int. J. Infect. Dis. 2020;101:232&#x2013;233. doi: 10.1016/j.ijid.2020.11.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.11.042</ArticleId></ArticleIdList></Reference><Reference><Citation>Department of Health (DoH) Philippine Integrated Disease Surveillance and Response. National Epidemiology Centre; Madrid, Spain: 2014.</Citation></Reference><Reference><Citation>Johnson B.W., Russell B.J., Lanciotti R.S. Serotype-specific detection of dengue viruses in a fourplex real-time reverse transcriptase PCR assay. J. Clin. Microbiol. 2005;43:4977&#x2013;4983. doi: 10.1128/JCM.43.10.4977-4983.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.43.10.4977-4983.2005</ArticleId><ArticleId IdType="pmc">PMC1248506</ArticleId><ArticleId IdType="pubmed">16207951</ArticleId></ArticleIdList></Reference><Reference><Citation>Biggs J.R., Sy A.K., Brady O.J., Kucharski A.J., Funk S., Reyes M.A.J., Quinones M.A., Jones-Warner W., Tu Y.-H., Avelino F.L., et al. A serological framework to investigate acute primary and post-primary dengue cases reporting across the Philippines. BMC Med. 2020;18:364. doi: 10.1186/s12916-020-01833-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01833-1</ArticleId><ArticleId IdType="pmc">PMC7694902</ArticleId><ArticleId IdType="pubmed">33243267</ArticleId></ArticleIdList></Reference><Reference><Citation>Sep&#xfa;lveda N., Stresman G., White M.T., Drakeley C.J. Current Mathematical Models for Analyzing Anti-Malarial Antibody Data with an Eye to Malaria Elimination and Eradication. J. Immunol. Res. 2015;2015:738030. doi: 10.1155/2015/738030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/738030</ArticleId><ArticleId IdType="pmc">PMC4684866</ArticleId><ArticleId IdType="pubmed">26770994</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucharski A.J., Kama M., Watson C.H., Aubry M., Funk S., Henderson A.D., Brady O.J., Vanhomwegen J., Manuguerra J.-C., Lau C.L., et al. Using paired serology and surveillance data to quantify dengue transmission and control during a large outbreak in Fiji. Elife. 2018;7:e34848. doi: 10.7554/eLife.34848.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.34848</ArticleId><ArticleId IdType="pmc">PMC6092126</ArticleId><ArticleId IdType="pubmed">30103854</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson A.D., Aubry M., Kama M., Vanhomwegen J., Teissier A., Mariteragi-Helle T., Paoaafaite T., Teissier Y., Manuguerra J.-C., Edmunds J., et al. Zika seroprevalence declines and neutralizing antibodies wane in adults following outbreaks in French Polynesia and Fiji. Elife. 2020;9:e48460. doi: 10.7554/eLife.48460.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.48460</ArticleId><ArticleId IdType="pmc">PMC6986872</ArticleId><ArticleId IdType="pubmed">31987069</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Barraquer I., Salje H., Cummings D.A. Opportunities for improved surveillance and control of dengue from age-specific case data. Elife. 2019;8:e45474. doi: 10.7554/eLife.45474.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.45474</ArticleId><ArticleId IdType="pmc">PMC6579519</ArticleId><ArticleId IdType="pubmed">31120419</ArticleId></ArticleIdList></Reference><Reference><Citation>Wikramaratna P.S., Simmons C.P., Gupta S., Recker M. The Effects of Tertiary and Quaternary Infections on the Epidemiology of Dengue. PLoS ONE. 2010;5:e12347. doi: 10.1371/journal.pone.0012347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0012347</ArticleId><ArticleId IdType="pmc">PMC2925950</ArticleId><ArticleId IdType="pubmed">20808806</ArticleId></ArticleIdList></Reference><Reference><Citation>Salje H., Paul K.K., Paul R. Nationally-representative serostudy of dengue in Bangladesh allows generalizable disease burden estimates. Elife. 2019;8:e42869. doi: 10.7554/eLife.42869.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.42869</ArticleId><ArticleId IdType="pmc">PMC6513551</ArticleId><ArticleId IdType="pubmed">30958263</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson A.D., Kama M., Aubry M., Hue S., Teissier A., Naivalu T., Bechu V.D., Kailawadoko J., Rabukawaqa I., Sahukhan A., et al. Interactions between timing and transmissibility explain diverse flavivirus dynamics in Fiji. Nat. Commun. 2021;12:1&#x2013;9. doi: 10.1038/s41467-021-21788-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21788-y</ArticleId><ArticleId IdType="pmc">PMC7961049</ArticleId><ArticleId IdType="pubmed">33723237</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho Z.J.M., Hapuarachchi H.C., Barkham T., Chow A., Ng L.C., Lee J.M.V., Leo Y.S., Prem K., Lim Y.H.G., de Sessions P.F., et al. Outbreak of Zika virus infection in Singapore: An epidemiological, entomological, virological, and clinical analysis. Lancet Infect. Dis. 2017;17:813&#x2013;821. doi: 10.1016/S1473-3099(17)30249-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(17)30249-9</ArticleId><ArticleId IdType="pubmed">28527892</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>